Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Avatar Builder | Contact Info | Update Email | Update Password | Leaderboards | Manage Favourite | Reputation | Reputation History | Subscriptions | Payment Info | Invoices | Favourites

Bullboard Post History

by Whitman19

Order by:

C.DRUG	Upcoming catalysts The next couple of catalysts include the toxicology study for 5HT2A to treat... April 13, 2022
C.DRUG	RE:Bright Minds Moves Into Clinical Development Stage Following That's wonderful. Just waiting for the stock to take off March 25, 2022
C.DRUG	BMB-101 is all set to hit the clinic in H1’22 Unlike most biotechs developing drugs from naturally occurring psychedelics... January 10, 2022
C.DRUG	THE MOST POTENT NOVEL PSYCHEDELICS EVER CREATED... "I would say we have the largest and most advanced psychedelic drug... December 29, 2021
C.DRUG	BMB: The next-gen psychedelics to treat neuro conditions Bright Minds has a portfolio of three patented mechanisms based on serotonin ... December 2, 2021
C.DRUG	RE:Bright Minds Bioscience Approved For Nasdaq Listing This is one of the best news for the psychedelic sector in a long time...Way... November 3, 2021
C.DRUG	Ian McDonald's interview with James Hallifax Watch Ian McDonald, CEO of Bright Minds Biosciences' interview with James... October 5, 2021
C.DRUG	RE:Bright Minds Biosciences Proprietary Compound Shows Reductio Bright Minds looks all set to begin clinical trials on their New Chemical... October 4, 2021
C.DRUG	BMB- A Search For GW Pharmaceuticals In The Psilocybin Space Here's an amazing research report from Colin Sullivan making the case for... July 6, 2021
C.DRUG	Brom to interview BMB CEO on "The Integration Conversation" Brom is interviewing Bright Minds CEO Ian McDonald and VP of Discovery Dr... July 1, 2021
C.DRUG	WATCH Dr GIDEON SHAPIRO'S INTERVIEW ON THE DEEP DIVE Watch this very informative video to know more about the various serotonin... June 24, 2021
C.DRUG	BMBIF Nasdaq uplisting I'm buying on every decline and hope to have at least 2k shares before... June 21, 2021
C.DRUG	5HT2C- The primary receptor for advanced neuro therapies Neurological disorders are on the rise, and the few existing drugs in the... May 13, 2021
C.DRUG	Insider buying in DRUG Ian McDonald, the co-founder and CEO of Bright Minds Biosciences recently... March 23, 2021
C.DRUG	Insider buying in DRUG Ian McDonald, the co-founder and CEO of Bright Minds Biosciences recently... March 23, 2021
C.DRUG	DRUG reduces binge eating by 50% Wow, is this something we've all been waiting for or what? Binge eating... March 5, 2021
C.DRUG	The history & future of Magic Mushrooms The rise, fall and the resurgence of psilocybin...Here are the highlights of... February 18, 2021
C.DRUG	RE:RE:RE:new listing today? Ya, right. I don't think it will drop even below it's opening price... February 18, 2021
PFE	Moderna No one's even talking about the EUA for the Moderna vaccine. The way... December 11, 2020

Featured News Links

Stage Set for Creation of a Leading Intermediate Gold Producer

Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study

Discover a Green Resources Stock Scoring Record Quarterly Growth

Featured Company

Fobi AI Inc V.FOBI

Fobi AI Inc. is a Canada-based artificial intelligence (AI) and data intelligence company. The Company operates in the ... view more »